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Introduction
In 2015 Wellcome Trust and Epic Games ran a challenge - pairing 
computer games developers with researchers - to develop visuali-
sation methods in virtual reality (VR) for big biomedical datasets 
from the following Wellcome Trust funded research projects:
1.    A collection of historical medical records from the Case-
books Project
2.    Genomics data from the Sanger Institute
3.    Cohort data from the ALSPAC study (also known as Chil-
dren of the Nineties)
University of Bristol researchers were paired with team Luma 
Pie (comprising Masters of Pie http://www.mastersofpie.com and 
Lumacode http://www.lumacode.com), who won the challenge 
with the vARC concept designed to visualise complex cohort data 
from the ALSPAC study. The Masters of Pie blog records vARC 
development (part 1, http://www.mastersofpie.com/big-data-vr-
challenge/ and part 2 http://www.mastersofpie.com/big-data-vr-
challenge-phase-2-update/), and a description of the challenge 
winning vARC prototype (http://www.mastersofpie.com/big-data-
vr-challenge-winners/).
The value of this emerging technology and its potential applica-
tions to e-health and wider use in medicine was recognised by 
the winning collaboration who continue the development of a VR 
proof-of-concept biomedical data exploration and visualisation 
tool under the Big Data VR project using the ALSPAC cohort 
study as a use case. This project has additionally explored a variety 
of VR visual analytic methodologies, investigated VR analytics 
applied to different scales of data and scoped the integration of 
privacy protecting analytical methods via DataSHIELD1. Findings 
will be reported in a forthcoming paper.
Due to the nature of the Big Data VR project, it was necessary to 
use a dataset that could be freely shared across the project team 
of researchers and games developers, as well as be deployed as 
an open test dataset for a demo release of the Big Data VR tool. 
There exist, however, ethical-legal constraints on the open shar-
ing of, or access to, biomedical study data due to concerns around 
participant privacy and disclosure risk. ALSPAC deploys a 
rigorous data governance and access policy to protect participant 
data confidentiality and disclosure. This meant that we could 
not simply share real ALSPAC data with the developers without 
going through a potentially lengthy process of formally assess-
ing the bona-fides of every single person in the development team 
who may need to work with or see the data. Given the very short 
time scale of the project this was not feasible. However, in order 
to properly challenge the developers and their evolving tools, and 
to ensure that the tools would ultimately be useful in a meaningful 
scientific context, it was nevertheless important that the test datasets 
closely mirrored real ALSPAC data. To ensure privacy protection, 
it was therefore necessary to generate synthetic datasets to be used 
in the project, an approach commonly utilised within the research 
health data domain2. This paper outlines three synthetic datasets 
simulated from ALSPAC study data for the purposes of the Big 
Data VR project.
Methods
Based at the University of Bristol, ALSPAC (also known as 
Children of the 90s) studies the health and well-being of preg-
nancies from the Avon region - with children born between 
1991–1992. The whole cohort includes children from original 
enrolment (phase I recruitment), as well as children invited to 
join from the age of 7 onwards (from phase II and III recruit-
ment), n = 15445 participants (excluding triplets and quadruplets) 
at the time of this work. Cohort profiles are described in Boyd 
et al.3, Fraser et al.4 and the study website contains details of 
all the data that is available through a fully searchable data 
dictionary (http://www.bris.ac.uk/alspac/researchers/data-access/
data-dictionary/). The variables from 15445 ALSPAC child par-
ticipants used for the simulated data generation are outlined in 
Table 1. They include cardiac measures (i.e. blood pressure and 
pulse rate) and anthropometric measures (i.e. height, sitting 
height, weight, bmi, hip and waist circumference) of children vis-
iting different ALSPAC clinics. The age indicated at each clinic 
is the age of the child at attendance, which is calculated from 
the date of the visit and the child’s date of birth. All variables 
used were continuous, except gender which is a binary variable 
(with 1 indicating male and 2 indicating female). The coverage 
of these variables at different clinic ages is shown in Table 2, 
highlighting any variables missing from collection.
Synthetic data was simulated using the statistical programming 
language R (5, version 3.2.3) comprising the following steps with 
the corresponding R functions noted in line:
Data cleaning
The ALSPAC dataset described in Table 1 and Table 2 was 
cleaned by removing all rows with missing values, leaving 1593 
observations remaining.
Standardising continuous variables







where z denotes the standardised version of the variable, with µ 
and σ representing the mean and standard deviation of x , respec-
tively (using mean() and sd()). This z-score transformation was 
used to transform normally distributed data N (µ, σ) to standard 
normally distributed data N (0, 1).
Data generation: Continuous variables
It was assumed that the continuous variables (excluding BMI) fol-
low an approximate multivariate normal distribution. Using the 
pseudo-random multivariate normal generator (mvrnorm()), 
three synthetic datasets were generated of observation sizes 
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Table 1. A description of the ALSPAC variables used to 







f7ms010 Height (cm): F@7 height.7
f7ms012 Sitting height (cm): F@7 height.sit.7
f7ms018 Waist circumference (cm): F@7 waist.7
f7ms020 Hip circumference (cm): F@7 hip.7
f7ms026 Weight (kg): F@7 weight.7
f7ms026a BMI: F@7 BMI
f7sa021 Mean BP systolic: samples F@7 sbp.7
f7sa022 Mean BP diastolic: samples F@7 dbp.7
f7sa023 Mean Pulse: samples F@7 pulse.7
f7003c Age (months) at Focus @ 7 visit age.7
f8lf020 Child height (cm): LF, F@8 height.8
f8lf021 Child weight (kg): LF, F@8 weight.8
f8003c Age (months) at Focus @ 8 visit age.8
f9ms010 Height (cm): F@9 height.9
f9ms012 Sitting height (cm): F@9 height.sit.9
f9ms018 Waist circumference (cm): F@9 waist.9
f9ms020 Hip circumference (cm): F@9 hip.9
f9ms026 Weight (kg): F@9 weight.9
f9ms026a BMI: F@9 BMI.9
f9sa021 Mean BP systolic: samples F@9 sbp.9
f9sa022 Mean BP diastolic: samples F@9 dbp.9
f9sa023 Mean Pulse: samples F@9 pulse.9
f9003c Age (months) at Focus @ 9 visit age.9
fdms010 Height (cm): F10+ height.10
fdms012 Sitting height (cm): F10+ height.sit.10
fdms018 Waist circumference (cm): F10+ waist.10
fdms026 Weight (kg): F10+ weight.10
fdms026a BMI: F10+ BMI.10
SBP Systolic blood pressure_AS sbp.10
DBP Diastolic blood pressure_AS dbp.10
fd003c Age (months) at F10+ visit age.10
fems010 Height (cm): F11+ height.11
fems012 Sitting height (cm): F11+ height.sit.11
fems018 Waist circumference (cm): F11+ waist.11






fems026 Weight (kg): F11+ weight.11
fems026a BMI: F11+ BMI.11
fesa021 Mean BP systolic: samples F11+ sbp.11
fesa022 Mean BP diastolic: samples F11+ dbp.11
fesa023 Mean Pulse: samples F11+ pulse.11
fe003c Age (months) at F11+ visit age.11
ff2000 M5: Height (cms) height.12
ff2005 M7: Sitting height (cms) height.sit.12
ff2020 M11: Waist circumference (cms) waist.12
ff2620 B8: BP result 1 - systolic sbp.12
ff2621 B9: BP result 1 - diastolic dbp.12
ff2622 B10: BP result 1 - pulse pulse.12
ff0011a DV: Age of study child at attendance (months) age.12
fg3100 M5: Height (cms) : TF2 height.13
fg3120 M11: Waist circumference (cms) : TF2 waist.13
fg3130 M15: Weight (Kgs) : TF2 weight.13
fg6120 B15: BP result 1 - systolic : TF2 sbp.13
fg6121 B16: BP result 1 - diastolic : TF2 dbp.13
fg6122 B17: BP result 1 - pulse : TF2 pulse.13
fg0011a DV: Age of study child at attendance (months) TF2 age.13
fh3000 M5: Height (cms) : TF3 height.15
fh3010 M15: Weight (Kgs) : TF3 weight.15
fh4020 M11: Waist circumference (cms) : TF3 waist.15
fh4030 V6: Sitting height (cms) : TF3 height.sit.15
fh2030 AC18: BP result 1 - systolic : TF3 sbp.15
fh2031 AC19: BP result 1 - diastolic : TF3 dbp.15
fh2032 AC20: BP result 1 - pulse : TF3 pulse.15
fh0011a DV: Age of study child at attendance (months) TF3 age.15
FJMR020 M5: Height (cms) [F17] height.17
FJMR022 M15: Weight (kgs) [F17] weight.17
FJAR020a dv: Right arm BP mean: systolic sbp.17
FJAR020b dv: Right arm BP mean: diastolic dbp.17
FJAR020c dv: Right arm BP mean: pulse pulse.17
FJMR022a dv: BMI [F17] bmi.17
FJ003a Age in months at clinic visit [F17] age.17
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Table 2. A summary of data capture in clinics for the respective ALSPAC variables.
Variable (units) F@7 F@8 F@9 F@10 F@11 TF1 TF2 TF3 TF4
Gender (1 male, 2 female) yes yes yes yes yes yes yes yes yes
Exact Age (months) yes yes yes yes yes yes yes yes yes
Height (cm) yes yes yes yes yes yes yes yes yes
Sitting Height (cm) yes NA yes yes yes yes NA yes NA
Waist Circumference (cm) yes NA yes yes yes yes yes yes NA
Hip Circumference (cm) yes NA yes NA yes NA NA NA NA
Weight (kg) yes yes yes yes yes yes yes yes yes
Systolic Blood Pressure (mmHg) yes NA yes yes yes yes yes yes yes
Diastolic Blood Pressure (mmHg) yes NA yes yes yes yes yes yes yes
Pulse (Beats per minute) yes NA yes NA yes yes yes yes yes
BMI (kg/m2) yes NA yes yes yes NA NA NA yes
15500, 155000 and 1550000 participants. Using the assumption 
of approximate multivariate normality (without transforming any 
non-normal data to normal), the synthetic data do not have pre-
cisely the same joint and marginal distributions as the original 
ALSPAC data, but they have very accurate approximations with 
most variables passing formal tests of normality. The simulated 
continuous variables were then rescaled back to their original mean 
and standard deviation by the inverse z-score transformation:
X = Zσ + μ
where X and Z denote the simulated data for x and z respectively, 
with µ and σ representing (as above) the mean and standard 
deviation of the real x data.
Data generation: Binary variables
The simulated gender variable retains the same proportions of 
males and females as that in the original ALSPAC data set. This 
was achieved by converting the levels 1-2 (indicating males and 
females respectively) to 0-1 data and then applying a logistic model 
for gender regressed (glm()) on all continuous variables using the 
original dataset. The estimated coefficients were then used to calcu-
late the linear predictors of the simulated datasets. Then, using the 
log odds, y, from the linear predictors, we have calculated the odds, 
p, that indicate the probability ratio between males and females, 








The simulated binary variable denoting gender in each subject 
was then generated using the value of p in that individual (derived 
from the expit transformation) as the probability argument in R’s 
rbinom() function.
Data generation: BMI variable
The simulated BMI variable was calculated from the simulated val-
ues of weight and height for the clinics F@7, F@9, F@10, F@11 






Data generation: Age variable
The age at each clinic, initially reported in months, was divided 
by 12 to represent its values in years. The simulated age variable 
at each clinic was generated assuming normality and using the 
rnorm() R function with mean and variance set equal to the 
actual mean and variance of age at each clinic.
Dataset validation
Three synthetic datasets were simulated using the methodology 
described above - with observation size 15,500 participants 
(simulated.data.1.csv), 155,500 participants (simulated.data.2.csv) 
and 1,555,000 participants (simulated.data.3.csv). Table 1 shows 
the data dictionary for these.
The three synthetic datasets have similar properties to the 
ALSPAC data they are simulated from. This is demonstrated 
by the close similarity of the estimated means, variances and 
covariance matrices for the relevant variables in the original 
ALSPAC dataset and the three synthetic datasets (see Supplementary 
material). The synthetic datasets contain none of the original 
data itself.
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Data and software availability
1.    The ALSPAC dataset (project number B2506) these 
synthetic data are simulated from can be obtained from 
ALSPAC through the standard ALSPAC research proposal 
and data access policy http://www.bristol.ac.uk/alspac/
researchers/access/.
2.    The script to generate the three synthetic datasets. https://
doi.org/10.5281/zenodo.8175026
3.    The synthetic data described in this paper are available 
at the University of Bristol data repository, data.bris, at 
https://doi.org/10.5523/bris.3116aupg8mfgi23pnslu8tulev7
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Supplementary material
Supplementary File 1: The variable mean for the ALSPAC dataset and the three synthetic datasets.
Click here to access the data.
Supplementary File 2: The variable variance for the ALSPAC dataset and the three synthetic datasets.
Click here to access the data.
Supplementary File 3: The covariance matrix of the cleaned ALSPAC data (1593 participants) used for simulating the synthetic datasets.
Click here to access the data.
Supplementary File 4: The covariance matrix of the synthetic dataset simulated.data.1.csv (15,500 participants).
Click here to access the data.
Supplementary File 5: The covariance matrix of the synthetic dataset simulated.data.2.csv (155,500 participants).
Click here to access the data.
Supplementary File 6: The covariance matrix of the synthetic dataset simulated.data.3.csv (1,555,500 participants).
Click here to access the data.
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